1Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
2Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
3Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
4Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
5Department of Internal Medicine, Busan St. Mary's Hospital, Catholic University of Pusan, Busan, Korea.
6Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
7Department of Internal Medicine, Daedong Hospital, Busan, Korea.
8Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
9Department of Internal Medicine, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.
Copyright © 2020 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: This study was funded by Takeda Pharmaceuticals Korea Co.
AUTHOR CONTRIBUTIONS:
Conception or design: S.S.K., I.J.K.
Acquisition, analysis, or interpretation of data: J.M.K., S.S.K., J.H.K., M.K.K., T.N.K., S.H.L., C.W.L., J.Y.P., E.S.K., K.J.L., Y.S.C., D.K.K., I.J.K.
Drafting the work or revising: J.M.K., S.S.K., I.J.K.
Final approval of the manuscript: J.M.K., S.S.K., J.H.K., M.K.K., T.N.K., S.H.L., C.W.L., J.Y.P., E.S.K., K.J.L., Y.S.C., D.K.K., I.J.K.
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
ITT, intention-to-treat; BMI, body mass index; HbA1c, glycosylated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol.
Values are presented as mean±standard deviation. P<0.05 was considered significant.
HbA1c, glycosylated hemoglobin; ITT, intention-to-treat; PP, per-protocol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment as an index of insulin resistance; HOMA-β, homeostatic model assessment β-cell function.